Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/breast-mri-biopsy-cancellation-due-to-lesion-nonvisualization-tEzwUGOJq7
References (16)
-
(2020)
Breast MRI biopsy cancellation due to lesion nonvisualization -
Sandra Brennan, J. Sung, D. Dershaw, L. Liberman, Elizabeth Morris (2011)
Cancellation of MR imaging-guided breast biopsy due to lesion nonvisualization: frequency and follow-up.Radiology, 261 1
-
N. Pinnamaneni, L. Moy, Yiming Gao, Amy Melsaether, J. Babb, H. Toth, S. Heller (2018)
Canceled MRI-guided Breast Biopsies Due to Nonvisualization: Follow-up and Outcomes.Academic radiology, 25 9
-
Emily Ambinder, K. Myers, Babita Panigrahi, Lisa Mullen, S. Harvey, Jessica Hung, E. Oluyemi (2020)
Breast MRI BI-RADS 3: Impact of Patient-Level Factors on Compliance With Short-Term Follow-Up.Journal of the American College of Radiology : JACR
-
C. Perlet, A. Heinig, X. Prat, J. Casselman, L. Bååth, H. Sittek, C. Stets, JM Lamarque, I. Anderson, P. Schneider, P. Taourel, M. Reiser, S. Heywang-Köbrunner (2002)
Multicenter study for the evaluation of a dedicated biopsy device for MR-guided vacuum biopsy of the breastEuropean Radiology, 12
-
D. Monticciolo, M. Newell, L. Moy, Bethany Niell, B. Monsees, E. Sickles (2018)
Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.Journal of the American College of Radiology : JACR, 15 3 Pt A
-
R. Gutierrez, Wendy DeMartini, P. Eby, B. Kurland, S. Peacock, C. Lehman (2009)
BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.AJR. American journal of roentgenology, 193 4
-
J. Baum, Lucy Hanna, S. Acharyya, M. Mahoney, E. Conant, L. Bassett, E. Pisano (2011)
Use of BI-RADS 3-probably benign category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening Trial.Radiology, 260 1
-
L. Liberman, Nanette Bracero, E. Morris, Cynthia Thornton, D. Dershaw (2005)
MRI-guided 9-gauge vacuum-assisted breast biopsy: initial clinical experience.AJR. American journal of roentgenology, 185 1
-
Karen Johnson, J. Baker, Sheila Lee, M. Soo (2013)
Cancelation of MRI guided breast biopsies for suspicious breast lesions identified at 3.0 T MRI: reasons, rates, and outcomes.Academic radiology, 20 5
-
Bethany Niell, Janie Lee, C. Johansen, E. Halpern, E. Rafferty (2014)
Patient outcomes in canceled MRI-guided breast biopsies.AJR. American journal of roentgenology, 202 1
-
P. Viehweg, T. Bernerth, M. Kiechle, J. Buchmann, A. Heinig, H. Koelbl, M. Laniado, S. Heywang-Köbrunner, S. Heywang-Köbrunner (2006)
MR-guided intervention in women with a family history of breast cancer.European journal of radiology, 57 1
-
Babita Panigrahi, S. Harvey, Lisa Mullen, Eniola Falomo, Philip Carlo, Bonmyong Lee, K. Myers (2019)
Characteristics and Outcomes of BI‐RADS 3 Lesions on Breast MRIClinical Breast Cancer, 19
-
B. Han, M. Schnall, S. Orel, M. Rosen (2008)
Outcome of MRI-guided breast biopsy.AJR. American journal of roentgenology, 191 6
-
Lukas Hefler, J. Casselman, B. Amaya, A. Heinig, T. Alberich, Heinz Koelbl, S. Heywang-Köbrunner (2003)
Follow-up of breast lesions detected by MRI not biopsied due to absent enhancement of contrast mediumEuropean Radiology, 13
-
C. Lehman, Wendy DeMartini, B. Anderson, S. Edge (2009)
Indications for breast MRI in the patient with newly diagnosed breast cancer.Journal of the National Comprehensive Cancer Network : JNCCN, 7 2
- Publisher
- Wiley
- Copyright
- Copyright © 2020 Wiley Periodicals, Inc.
- ISSN
- 1075-122X
- eISSN
- 1524-4741
- DOI
- 10.1111/tbj.14044
- Publisher site
- See Article on Publisher Site
Abstract
It is a clinical dilemma when a finding reported as suspicious on a breast MRI is not visualized at the time of a scheduled MRI‐guided breast biopsy. We retrospectively reviewed all canceled MRI‐guided biopsies at our institution between 6/1/2009 and 9/20/2019 and found a cancellation rate of 6.9% (72/1051). In one case, a mastectomy was performed after the canceled biopsy revealing a focus of DCIS in the same quadrant as the original finding (malignancy rate 2.1%). Our results support the current practice of 6‐month follow‐up MRI recommendation after a canceled MRI‐guided biopsy for lesion nonvisualization.
Journal
The Breast Journal – Wiley
Published: Oct 1, 2020
Keywords: ; ;